WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

B BLOOD AND BLOOD FORMING ORGANS
B06 OTHER HEMATOLOGICAL AGENTS
B06A OTHER HEMATOLOGICAL AGENTS

This group includes preparations for local and systemic use, and also some preparations used for dissolving clots in catheters, hemodialysis clots etc.
See also:
V07A - All other non-therapeutic products
B01AB - Heparin group


B06AA Enzymes

This group comprises enzymes with fibrinolytic properties. Enzymes with other well defined therapeutic use should be classified in the respective groups, see e.g.:
A09A - Digestives, incl. enzymes
B01AD - Enzymes
D03BA - Proteolytic enzymes
S01KX - Other surgical aids

B06AB Heme products

Givosiran indicated for acute hepatic porphyria is classified in A16AX -Various alimentary tract and metabolism products.

B06AC Drugs used in hereditary angioedema

The DDD for lanadelumab is based on the starting dose.

B06AX Other hematological agents

Glutamine for treatment of sickle cell disease is classified in A16AA03.

Last updated: 2024-01-26